Coronavirus RNA proofreading: molecular basis and therapeutic targeting
F Robson et al, Molecular Cell, August 5, 2020
F Robson et al, Molecular Cell, August 5, 2020
We review the molecular basis of the CoV proofreading complex and evaluate its potential as a drug target. We also consider existing nucleoside analogues and novel genomic techniques as potential anti-CoV therapeutics that could be used individually or in combination to target the proofreading mechanism.
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
KS Corbett et al, Nature, August 5, 2020
KS Corbett et al, Nature, August 5, 2020
Application of Social Vulnerability Index to Identify High- risk Population of Contracting COVID-19 Infection: a state-level study.
O Estefania et al, MEDRXIV, August 4, 2020
O Estefania et al, MEDRXIV, August 4, 2020
By applying the social vulnerability index and analyzing data from a total of 102 counties across the state of Illinois, we investigated which factors enhanced the risk of contracting the infection and which were related to a lower risk of infection.
Potent neutralizing antibodies target new regions of coronavirus spike
NIH Research Matters, August 4, 2020
NIH Research Matters, August 4, 2020
Covid-19 apps and wearables are everywhere. Can they actually benefit patients?
C Ross, StatNews, August 4, 2020
C Ross, StatNews, August 4, 2020
No hay comentarios:
Publicar un comentario